Search research articles
Contact Us
Filters
Showing results (31-40 of 84) with videos related to
Page
of 9
Sort By:
The Clinical Journal of Pain
|
September 20, 2022
Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
Karissa M Johnston, Lauren Powell, Evan Popoff, et al.
Advances in Therapy
|
January 17, 2023
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
Linda Harris, Tom O'Connell, Jonathan J Woolley, et al.
Neurology
|
January 15, 2020
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
Kathleen Mullin, David Kudrow, Robert Croop, et al.
Cerebellum (London, England)
|
December 10, 2022
Ataxia Rating Scales Reflect Patient Experience: an Examination of the Relationship Between Clinician Assessments of Cerebellar Ataxia and Patient-Reported Outcomes
Michele H Potashman, Miranda L Mize, Melissa W Beiner, et al.
Journal of Clinical Psychopharmacology
|
April 25, 2006
Visual hallucinations from the addition of riluzole to memantine and bupropion
Christopher Pittenger, Christine Naungayan, Steven F Kendell, et al.
Addiction Biology
|
September 11, 2008
Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women
Wendy J Lynch, Rasmon Kalayasiri, Atapol Sughondhabirom, et al.
Drug and Alcohol Dependence
|
November 2, 2005
Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia
Peter T Morgan, Edward F Pace-Schott, Zakir H Sahul, et al.
Addiction (Abingdon, England)
|
October 16, 2008
Sleep architecture, cocaine and visual learning
Peter T Morgan, Edward F Pace-Schott, Zakir H Sahul, et al.
Headache
|
October 14, 2022
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial
Robert Croop, Jennifer Madonia, David A Stock, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 11, 2020
Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym
Diane M Longo, Lisl K M Shoda, Brett A Howell, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 84) with videos related to
Sort By:
Page
of 9
The Clinical Journal of Pain
|
September 20, 2022
Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
Karissa M Johnston, Lauren Powell, Evan Popoff, et al.
Advances in Therapy
|
January 17, 2023
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
Linda Harris, Tom O'Connell, Jonathan J Woolley, et al.
Neurology
|
January 15, 2020
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
Kathleen Mullin, David Kudrow, Robert Croop, et al.
Cerebellum (London, England)
|
December 10, 2022
Ataxia Rating Scales Reflect Patient Experience: an Examination of the Relationship Between Clinician Assessments of Cerebellar Ataxia and Patient-Reported Outcomes
Michele H Potashman, Miranda L Mize, Melissa W Beiner, et al.
Journal of Clinical Psychopharmacology
|
April 25, 2006
Visual hallucinations from the addition of riluzole to memantine and bupropion
Christopher Pittenger, Christine Naungayan, Steven F Kendell, et al.
Addiction Biology
|
September 11, 2008
Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women
Wendy J Lynch, Rasmon Kalayasiri, Atapol Sughondhabirom, et al.
Drug and Alcohol Dependence
|
November 2, 2005
Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia
Peter T Morgan, Edward F Pace-Schott, Zakir H Sahul, et al.
Addiction (Abingdon, England)
|
October 16, 2008
Sleep architecture, cocaine and visual learning
Peter T Morgan, Edward F Pace-Schott, Zakir H Sahul, et al.
Headache
|
October 14, 2022
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial
Robert Croop, Jennifer Madonia, David A Stock, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 11, 2020
Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym
Diane M Longo, Lisl K M Shoda, Brett A Howell, et al.
Page
of 9